Delivery Order SPE2DB24D2205-SPE2DB25FEHVG
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order carries a ceiling value of $71,179.72 and is scheduled for ultimate completion by May 13, 2025. The award was made through open competition with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order (Contract No. 4569418933) by the Defense Logistics Agency on September 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The firm fixed-price contract has a ceiling value of $20,822.54 and an ultimate completion date of September 11, 2025. This award was made without a set-aside designation, indicating competitive procurement. The contract represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 25, 2025, for 60 tablets of Eliquis 5 mg. This competitively awarded, firm fixed-price contract has a ceiling value of $6,351.66 and an ultimate completion date of June 26, 2025. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $9,921.90, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 15, 2025. The contract will be performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $6,803.26. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,401.65 by the Defense Logistics Agency (DLA) on September 2, 2025, with completion targeted for September 3, 2025. The contract, issued under firm fixed price terms with no set-aside designation, calls for the delivery of 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This delivery order is a child contract executed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) with a ceiling value of $22,480.26. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,862.40 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHVGDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) with a ceiling value of $1,965.60. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime contract value of $999,999,999.00 and extends through December 2026. The DLA Troop Support Medical indefinite delivery vehicle serves as a comprehensive pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs globally. This contract vehicle facilitates AmerisourceBergen's supply of pharmaceutical products and medical supplies to critical customers including the Defense Health Agency and the U.S. Coast Guard. The DLA is currently planning the establishment of next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple regional awards, positioning AmerisourceBergen as a key strategic partner in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/19/25 |